Navigation Links
Bristol-Myers Squibb and WuXi PharmaTech Announce Collaboration for a New Analytical and Stability Testing Facility
Date:3/7/2011

NEW YORK and SHANGHAI, March 7, 2011 /PRNewswire-Asia/ -- Bristol-Myers Squibb Company (NYSE: BMY) and WuXi PharmaTech (NYSE: WX) today announced that they have entered a strategic partnership to conduct stability studies of small-molecule new chemical entities to support global marketing applications.

Under the agreement, WuXi will build, equip and operate a dedicated, fully cGMP-compliant 25,000-square-foot analytical testing facility in Shanghai to store and test stability samples and to perform other services for Bristol-Myers Squibb. WuXi will also employ a dedicated staff for stability testing, sample management, analytical testing, pharmaceutical science, quality assurance, metrology, and other services, including stability data reporting in support of all global dossier submissions by Bristol-Myers Squibb.

"This new agreement expands our already productive relationship with Bristol-Myers Squibb, a valued customer for many years," said Ge Li, Ph.D., chairman and chief executive officer of WuXi PharmaTech. "We will continue to help them to improve their R&D productivity with our innovation-driven, cost-effective and fully integrated R&D service platform."

"WuXi PharmaTech is an important partner for Bristol-Myers Squibb's research and development organization," said Mark Powell, Ph.D., senior vice president, Non-Clinical Development, Bristol-Myers Squibb. "This agreement will expand the scope of our relationship with WuXi and enhance the presence of Bristol-Myers Squibb in China. It is also an example of our R&D organization executing our company's BioPharma model by using selective integration to leverage the strengths and talents of both Bristol-Myers Squibb and a valued partner."

About Bristol-Myers SquibbBristol-Myers Squibb is a global biopharmaceut
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Bristol-Myers Squibb, New Jersey Childrens Hospital Launch Center for Immune System Disorders & Infectious Diseases Including HIV/AIDS
2. Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe
3. Top Bristol-Myers Squibb Executive Joins Patton Boggs
4. Isis Earns $6 Million Milestone Payment From Bristol-Myers Squibb for BMS-PCSK9Rx
5. Bend Research Announces Extension of Drug-Discovery Enablement and Development Services Agreement With Bristol-Myers Squibb
6. Bristol-Myers Squibb Sued for Denying Employees Overtime Pay
7. Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab
8. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
9. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
10. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
11. WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , January 23, 2015 Heptares Therapeutics, ... delighted to announce that the Malcolm Campbell Memorial ... (Vice President of Chemistry), Fiona Marshall (Chief ... Executive Officer and co-founder) for the seminal contributions to GPCR ...
(Date:1/22/2015)... UPI ), a medical device company that ... voiding dysfunctions, today reported financial results for the fiscal ... revenue for the Company,s Urgent ®  PC Neuromodulation System ... record, as compared to $3.9 million in the third ...
(Date:1/22/2015)... Corporation (NASDAQ: TECH ) announced today that ... new Simple Plex platform through its Proteins Platform division ... of the previously acquired CyPlex instrument platform from CyVek. ... immunoassay technology which integrates an innovatively designed microfluidic cartridge ...
Breaking Medicine Technology:Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18Bio-Techne Launches Simple Plex Platform 2Bio-Techne Launches Simple Plex Platform 3
... 12 Reportlinker.com announces that a new market ... Imaging Diagnostics Market In Poland 2010 ... http://www.reportlinker.com/p0311192/Imaging-Diagnostics-Market-In-Poland-2010---Development-Forecasts-For-2010-2012.html Imaging diagnostics market ... a clear picture of the current status of ...
... Announces Positive Results in Patients With Chronic Idiopathic Constipation From a... -- GOTHENBURG, Sweden, October 12, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we ...
Cached Medicine Technology:Reportlinker Adds Imaging Diagnostics Market in Poland 2010 - Development Forecasts for 2010-2012 2Reportlinker Adds Imaging Diagnostics Market in Poland 2010 - Development Forecasts for 2010-2012 3Reportlinker Adds Imaging Diagnostics Market in Poland 2010 - Development Forecasts for 2010-2012 4Reportlinker Adds Imaging Diagnostics Market in Poland 2010 - Development Forecasts for 2010-2012 5Reportlinker Adds Imaging Diagnostics Market in Poland 2010 - Development Forecasts for 2010-2012 6Reportlinker Adds Imaging Diagnostics Market in Poland 2010 - Development Forecasts for 2010-2012 7Reportlinker Adds Imaging Diagnostics Market in Poland 2010 - Development Forecasts for 2010-2012 8Reportlinker Adds Imaging Diagnostics Market in Poland 2010 - Development Forecasts for 2010-2012 9Reportlinker Adds Imaging Diagnostics Market in Poland 2010 - Development Forecasts for 2010-2012 10Reportlinker Adds Imaging Diagnostics Market in Poland 2010 - Development Forecasts for 2010-2012 11Reportlinker Adds Imaging Diagnostics Market in Poland 2010 - Development Forecasts for 2010-2012 12Reportlinker Adds Imaging Diagnostics Market in Poland 2010 - Development Forecasts for 2010-2012 13Reportlinker Adds Imaging Diagnostics Market in Poland 2010 - Development Forecasts for 2010-2012 14Reportlinker Adds Imaging Diagnostics Market in Poland 2010 - Development Forecasts for 2010-2012 15Albireo Announces Positive Results in Patients With Chronic Idiopathic Constipation From a Phase IIb trial of A3309 2Albireo Announces Positive Results in Patients With Chronic Idiopathic Constipation From a Phase IIb trial of A3309 3Albireo Announces Positive Results in Patients With Chronic Idiopathic Constipation From a Phase IIb trial of A3309 4Albireo Announces Positive Results in Patients With Chronic Idiopathic Constipation From a Phase IIb trial of A3309 5Albireo Announces Positive Results in Patients With Chronic Idiopathic Constipation From a Phase IIb trial of A3309 6Albireo Announces Positive Results in Patients With Chronic Idiopathic Constipation From a Phase IIb trial of A3309 7Albireo Announces Positive Results in Patients With Chronic Idiopathic Constipation From a Phase IIb trial of A3309 8Albireo Announces Positive Results in Patients With Chronic Idiopathic Constipation From a Phase IIb trial of A3309 9
(Date:1/22/2015)... Chemo Duck Program is pleased to announce the release of the ... with cancer. The Chemo Duck App, available on iTunes for use ... to help children of all ages living with cancer adjust to ... entertained, educated and at ease while waiting for clinic visits or ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue ... means to “Live Fearless.” , The “Faces of ... stories about how they or someone they know has faced ... in the moment. By telling these types of stories through ...
(Date:1/22/2015)... New York (PRWEB) January 22, 2015 ... after Fresenius Medical Care recalled its GranuFlo and NaturaLyte ... multidistrict litigation underway in U.S. District Court, District of ... dated January 20th, the Court has remanded a case ...
(Date:1/22/2015)... January 22, 2015 A study ... Medicine flagship journal Medicine & Science in Sports ... exercise may help reduce gastrointestinal (GI) problems associated ... , Participants in the double-blind, placebo-controlled study took ...
(Date:1/22/2015)... Payday lending practices in four southern ... financial distress to the states that permit them, according ... Center on Race and Wealth. , While they generate ... loans at the same time substantially depress economic activity, ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
... Debated, PHILADELPHIA, Oct. 28 Blood stored for ... current standard for blood storage, is,associated with a higher ... In a new study presented at CHEST 2008, the,74th ... Physicians (ACCP), researchers found that patients who received,transfusions with ...
... VirtualScopics, Inc.,(Nasdaq: VSCP ), a leading ... that on November 4, 2008 it will release ... ended September 30, 2008.,The company will host a ... 5, 2008 at 11:00 a.m. EST., VirtualScopics, ...
... to Public Health" Web Site, Hosts "Visit Day",at APHA ... The U.S. is facing a major public,health workforce ... shortage,will affect us all if action is not taken ... year, the Association of Schools of,Public Health (ASPH) completed ...
... Inc. (OTC,Bulletin Board: SCIE), a San Diego-based medical ... of its business., Jim Hitchin, SpectraScience,s CEO, ... to customers in both the United States and,Europe. ... leading research,facilities throughout the country including the Mayo ...
... solution to rejuvenate, restore and,refresh the face, NEW ... field of aesthetic surgery with the Y Lift, a ... of the face from the,forehead to jaw line to ... face lift., According to Dr. Trokel, a cosmetic ...
... SEPSIS MORTALITY , (Tuesday, October 28, 10:30 AM EST) ... is associated with lower mortality in patients with severe ... Pharmaceuticals reviewed hospital patient discharges from 500 US hospitals ... SS ranged from 64,000 in 2004 to 89,000 in ...
Cached Medicine News:Health News:'Old Blood' Linked To Infection 2Health News:'Old Blood' Linked To Infection 3Health News:VirtualScopics Schedules Third Quarter 2008 Earnings Announcement 2Health News:VirtualScopics Schedules Third Quarter 2008 Earnings Announcement 3Health News:ASPH and APHA Collaborate to Shore up the Public Health Workforce Pipeline: 2Health News:ASPH and APHA Collaborate to Shore up the Public Health Workforce Pipeline: 3Health News:SpectraScience Announces Updates 2Health News:SpectraScience Announces Updates 3Health News:The Y Lift 2Health News:New critical care research presented at CHEST 2008 2Health News:New critical care research presented at CHEST 2008 3Health News:New critical care research presented at CHEST 2008 4Health News:New critical care research presented at CHEST 2008 5Health News:New critical care research presented at CHEST 2008 6
McIntyre-Binkhorst, length 18 mm....
McIntyre-Binkhorst Cannula have a smooth blunt tip end opening....
Army/Navy retractor (set of 2)....
Jaffe wire lid retractor, large pair....
Medicine Products: